A enzima Paraoxonase-1 (PON1) possui atividades paraoxonase, arilestearase e lactonase, entre outras. É a mais estuda da família das PONs que é composta pela PON1, PON2 e PON3. Sugere-se, que todas atuam inibindo o processo de peroxidação lipídica de moléculas como a lipoproteína de baixa densidade (LDL) e alta densidade (HDL), caracterizando assim um possível papel anti-aterogênico. O gene da PON1 apresenta dois sítios polimórficos, com a troca de uma Gln192Arg (Q/R) e Met55Leu, que estão associados com diferenças na atividade e concentrações séricas da enzima. Por sua vez, indivíduos soropositivos para o HIV-1 apresentam alterações do metabolismo lipídico, que poderiam estar associados a alterações na atividade da PON1 e a terapia antirretroviral (TARV) com inibidores de protease (IP). O objetivo do estudo foi determinar as atividades séricas da PON1 e da arilestearase (ARE), e as freqüências alélicas dos polimorfismos genéticos da PON1 192QR e 55LM, e ainda, avaliar a correlação destes parâmetros com as alterações lipídicas em indivíduos soropositivos para o HIV-1 tratados com IP. No período de Setembro de 2009 até Junho de 2012, 174 indivíduos soropositivos e 46 soronegativos para o HIV-1 foram estudados. Foi realizada a genotipagem dos polimorfismos da PON1 192QR e 55LM através de PCR-RFLP. A atividade sérica da PON1/ARE foi avaliada por espectrofotometria empregando-se como substratos o paraoxon e o fenilacetato, respectivamente. O RNA-HIV-1 foi quantificado pelo método NASBA, e os linfócitos T-CD4+ e T-CD8+ por citometria de fluxo. Os níveis séricos de colesterol total, HDL, LDL, triglicérides (TG), ApoA1 e ApoB100 foram determinados e os anticorpos IgG anti-oxLDL por ELISA. A atividade sérica da PON1 foi inferior nos grupos de soropositivos, p<0,05, porém, a atividade ARE não apresentou diferenças entre os grupos estudados, p>0,05. Ambas as atividades não apresentaram relação com os genótipos PON1 192QR e 55LM, e estes genótipos apresentaram uma freqüência alélica semelhante ao grupo de soronegativos. Os níveis séricos de TG foram superiores nos grupos de soropositivos com TARV, p<0,05, enquanto o grupo tratado com IP apresentou níveis séricos de HDL e Apo-A1 inferiores aos demais grupos, p<0,05. Níveis séricos de Apo-B100, IgG anti-oxLDL, e o índice de risco aterogênico foram superiores no grupo tratado com IP, p<0,05. Concluí-se, que indivíduos soropositivos para o HIV-1 apresentaram alterações no metabolismo lipídico, principalmente nos tratados com IP, que adicionalmente apresentaram um maior índice de risco aterogênico e maiores níveis de anticorpos IgG anti-oxLDL. Estas alterações não apresentaram relação com os polimorfismos PON1 192QR e 55LM da PON1, e demonstraram que a atividade da enzima PON-1 esta diminuída em indivíduos soropositivos para o HIV-1 / The enzyme Paraoxonase-1 (PON1) has paraoxonase (PON), arylesterase (ARE) and lactonase activities, among others. It is the most studied member of PON family which is composed of PON1, PON2 and PON3. It is suggested that all members acts by inhibiting the peroxidation of lipid molecules as the low-density lipoprotein (LDL) and high-density lipoprotein (HDL), characterizing a potential anti-atherogenic effect. The PON1 gene has two mainly polymorphic sites, with an exchange of Gln192Arg (Q/R) and Met55Leu (L/M), which are associated with differences in activity and serum concentrations of the enzyme. In turn, seropositive individuals for HIV-1 show changes in lipid metabolism, which could be associated with changes in the activity of PON1 and highly active antiretroviral therapy (HAART) with protease inhibitors (PI). The aim of this study was to determinate the serum PON and ARE activities of PON1, the allele frequencies of PON1 192QR and PON1 55LM genetic polymorphisms and evaluate the correlation between these parameters and lipid abnormalities in seropositive patients for HIV-1 treated with IP. In the period from September 2009 until June 2012, 174 seropositive individuals and 46 soronegative individuals for HIV-1 were studied. We performed PON1 192QR and 55LM genotyping by PCR-RFLP. Serum activities PON and ARE of PON1 were evaluated by spectrophotometry using paraoxon and phenylacetate, respectively, as substrates. The HIV-1-RNA was quantified by the NASBA method, and lymphocytes T-CD4+ and T-CD8+, by flow cytometry. Serum levels of total cholesterol, HDL, LDL, triglycerides (TG), apoA1 and ApoB100 were determined. IgG anti-oxLDL antibodies were quantified by ELISA. The serum PON1 activity was lower in the seropositive group, p<0.05, however, ARE activity did not differ between groups, p>0.05. Both activities had no relation with the PON1 192QR and PON1 55LM genotype, and these individuals showed an allele frequency similar to the seronegative group. Serum levels of TG were higher in groups of HIV-positive with HAART, p<0.05, while the IP-treated group showed serum levels of HDL and ApoA1 lower than other groups, p <0.05. Serum levels of ApoB100, IgG anti-oxLDL antibodies, and atherogenic risk indices were higher in the group treated with PI, p<0.05. It was concluded that individuals HIV-1-infected showed changes in lipid metabolism, especially in those treated with IP, which additionally showed a higher rate of atherogenic risk and higher levels of IgG anti-oxLDL antibodies. These changes did not correlated with PON1 192QR and 55LM polymorphisms and demonstrated that the activity of PON1enzyme is decreased in individuals seropositive for HIV-1

Les nanomatériaux représentent un créneau de recherche en plein essor dans de nombreuxdomaines. Leurs propriétés inédites leur confèrent de nombreux avantages mais soulèvent égalementdes interrogations quant à leur profil toxicologique. Parmi leurs applications possibles, lesnanomatériaux sont intégrés au sein de topiques protecteurs : dans le secteur militaire, afin de limiterla pénétration cutanée des agents chimiques de guerre et dans le secteur cosmétique, notammentdans les produits de protection solaire. Ce travail porte sur l'intérêt du dioxyde de cérium pur ou dopéau calcium dans ces deux applications. Dans un premier temps, les nanoparticules ont étésynthétisées par une méthode hydrothermale, assistée de la voie micro-ondes. La caractérisation pardifférentes méthodes a permis d'identifier la phase cristalline du CeO2 et a montré que lesnanoparticules présentaient une taille de 3 nm, pouvant être augmentée jusqu'à 95 nm en fonction dutraitement thermique appliqué. Par la suite, l'efficacité des nanoparticules seules puis incorporées ausein de topiques à effets barrières vis-à-vis de la pénétration du paraoxon, agent organophosphoré, aété testée. Une émulsion H/E constituée de 10 % de cérine a permis de réduire de façon significativela pénétration du toxique. Enfin, la photoprotection et la sécurité d'emploi du CeO2 ont été comparéesà celles des filtres solaires, et notamment à celles de l'oxyde de zinc (ZnO) fréquemment rencontrédans les produits de protection solaire. Le CeO2, en améliorant la protection dans le domaine des UVBet en ne présentant aucun effet antiprolifératif ou génotoxique sur une lignée cellulaire dekératinocytes humains, représente une alternative particulièrement intéressante au ZnO. / Nanomaterials represent a growing niche research in many fields. Their unusual properties provide many benefits, but also raise questions about their toxicological profile. Among their applications, nanomaterials are integrated into topical skin protectant: in the military sector, in order to reduce skin penetration of chemical warfare agents and in the cosmetics industry, especially in sunscreen products. This work focuses on the interest of pure or calcium doped cerium dioxide in these two applications. Initially, the nanoparticles were synthesized by a microwave-hydrothermal method. Characterization by different methods has identified the crystalline phase of CeO2 and has showed that the nanoparticles had a size of 3 nm, which could be increased up to 95 nm depending on the heat treatment applied. Thereafter, the effectiveness of nanoparticles alone and then incorporated in a topical barrier cream over the penetration of paraoxon, organophosphorus agent was tested. An O/W emulsion, consisting of 10 % ceria, has reduced significantly the penetration of the toxic. Finally, photoprotection and safety of CeO2 were compared with sunscreens, and in particular with zinc oxide (ZnO), frequently encountered in sunscreen products. CeO2, improving protection in the UVB range and showing no antiproliferative or genotoxic effect on human keratinocyte cell line, is a particularly attractive alternative to ZnO.

Made available in DSpace on 2016-06-02T19:29:57Z (GMT). No. of bitstreams: 1 5307.pdf: 3018065 bytes, checksum: 4a4ed79b44dafeeb1204798dc8f70256 (MD5) Previous issue date: 2013-06-03 / Universidade Federal de Sao Carlos / This thesis aimed to evaluate the use of cholinesterases (ChE) of the cladoceran species Pseudosida ramosa and Daphnia magna as a biochemical biomarker of the presence and effects of anatoxin-a(s) at different levels of biological organization (molecular, individual and population), besides the combined effects of the mixtures of the hepatotoxic (microcystins) and neurotoxic (anatoxin-a(s)) extracts in D. magna. A microplate assay was adapted and optimized for measuring the ChE activity of P. ramosa, in order to produce an assay protocol for this species. The analysis on the performance of ChE assays in P. ramosa showed that these are suitable for the quantifying of enzymatic activity in this species. P. ramosa showed to be an adequate alternative to the exotic cladoceran D. magna. Thus, it was proposed an assay protocol, which it meets the best combination of parameters for the using of ChE activity of P. ramosa as a biochemical biomarker. The ChE activity of P. ramosa and D. magna were specific for the indication of the presence of anatoxin-a(s), since no effect on the enzymatic activity of these species was observed when they were exposed to the microcystins. In the acute exposures (48-h) to the anatoxin-a(s) extract and to the paraoxon-methyl, P. ramosa was more sensitive than D. magna for ChE activity and survival endpoints. Also, P. ramosa was more sensitive than D. magna when exposed to the anatoxin-a(s) extract for 7 days. When the relationships between the ChE inhibition and individual and populational endpoints were evaluated, different responses were observed for the studied species. The ChE inhibition in P. ramosa had a very close relationship with the survival in the acute exposures to the anatoxin-a(s) extract and to the paraoxon-methyl. For D. magna, on the other hand, this relationship was not linear, being high levels of ChE inhibition associated with almost no mortality. The ChE activity in P. ramosa was also a good predictor of the chronic effects of anatoxin-a(s) extract at higher levels of biological organization, since ChE inhibition (48 h) was linearly linked to the sub-lethal effects on the reproduction (21 days) and on the population growth rate (21 days). For D. magna, these relationships could not be established, possibly due to species-specific differences in the affinities of both acetylcholinesterase and pseudocholinesterases to the toxicants. Thus, for the using of ChE as a biochemical biomarker in the risk assessments of neurotoxic cyanobacteria blooms in tropical regions, it is recommended the use of native species, especially of P. ramosa, since the model species D. magna could overestimate the risk to the local species. When the effects of the mixtures of the hepatotoxic and neurotoxic extracts were evaluated on the survival and feeding rates of D. magna, additive and synergistic responses were only observed on the feeding rates. Therefore, since different types of cyanotoxins are found in the natural environments in combination, the risks of these toxins on the zooplanktonic community should be evaluated not only individually, but also as mixtures. / Esta tese teve como objetivo avaliar o uso das colinesterases (ChE) das espécies de cladóceros Pseudosida ramosa e Daphnia magna como um biomarcador bioquímico da presença e dos efeitos de anatoxina-a(s) em diferentes níveis de organização biológica (molecular, individual e populacional), além dos efeitos combinados das misturas dos extratos hepatotóxicos (microcistinas) e neurotóxicos (anatoxina-a(s)) em D. magna. Um ensaio de microplacas foi adaptado e otimizado para medir a atividade de ChE da P. ramosa, a fim de produzir um protocolo de ensaio para esta espécie. A análise sobre o desempenho dos ensaios de ChE em P. ramosa mostrou que estes são adequados para a quantificação da atividade enzimática nesta espécie. P. ramosa mostrou ser uma alternativa adequada para o cladócero exótico D. magna. Assim, foi proposto um protocolo de ensaio, o qual reúne a melhor combinação de parâmetros para a utilização da atividade de ChE da P. ramosa como um biomarcador bioquímico. A atividade de ChE da P. ramosa e da D. magna foram específicas para a indicação da presença de anatoxinaa( s), uma vez que nenhum efeito sobre a atividade enzimática dessas espécies foi observado quando elas foram expostas às microcistinas. Nas exposições agudas (48 h) ao extrato de anatoxina-a(s) e ao paraoxon-metil, P. ramosa foi mais sensível do que D. magna para os parâmetros atividade de ChE e sobrevivência. Também, P. ramosa foi mais sensível do que D. magna quando exposta ao extrato de anatoxina-a(s) por sete dias. Quando as relações entre a inibição de ChE e os parâmetros individuais e populacionais foram avaliados, diferentes respostas foram observadas para as espécies estudadas. A inibição de ChE em P. ramosa teve uma relação muito próxima com a sobrevivência nas exposições agudas ao extrato de anatoxina-a(s) e ao paraoxon-metil. Para D. magna, por outro lado, esta relação não foi linear, sendo níveis altos de inibição de ChE associados com quase nenhuma mortalidade. A atividade de ChE em P. ramosa foi também um bom preditor dos efeitos crônicos do extrato de anatoxina-a(s) em níveis mais elevados de organização biológica, uma vez que a inibição de ChE (48 h) foi associada linearmente aos efeitos sub-letais na reprodução (21 dias) e na taxa de crescimento populacional (21 dias). Para D. magna, essas relações não puderam ser estabelecidas, possivelmente devido a diferenças espécie-específicas nas afinidades da acetilcolinesterase e das pseudocolinesterases aos tóxicos. Assim, para a utilização de ChE como um biomarcador bioquímico nas avaliações de risco de florescimentos de cianobactérias neurotóxicas em regiões tropicais, recomenda-se o uso de espécies nativas, especialmente da P. ramosa, uma vez que a espécie modelo D. magna poderia superestimar o risco para as espécies locais. Quando os efeitos das misturas dos extratos hepatotóxicos e neurotóxicos foram avaliados sobre a sobrevivência e as taxas alimentares da D. magna, respostas aditivas e sinergísticas foram observadas apenas nas taxas alimentares. Portanto, uma vez que diferentes tipos de cianotoxinas são encontrados nos ambientes naturais em combinação, os riscos dessas toxinas sobre a comunidade zooplanctônica deveriam ser avaliados não apenas individualmente, mas também como misturas.

A enzima Paraoxonase-1 (PON1) possui atividades paraoxonase, arilestearase e lactonase, entre outras. É a mais estuda da família das PONs que é composta pela PON1, PON2 e PON3. Sugere-se, que todas atuam inibindo o processo de peroxidação lipídica de moléculas como a lipoproteína de baixa densidade (LDL) e alta densidade (HDL), caracterizando assim um possível papel anti-aterogênico. O gene da PON1 apresenta dois sítios polimórficos, com a troca de uma Gln192Arg (Q/R) e Met55Leu, que estão associados com diferenças na atividade e concentrações séricas da enzima. Por sua vez, indivíduos soropositivos para o HIV-1 apresentam alterações do metabolismo lipídico, que poderiam estar associados a alterações na atividade da PON1 e a terapia antirretroviral (TARV) com inibidores de protease (IP). O objetivo do estudo foi determinar as atividades séricas da PON1 e da arilestearase (ARE), e as freqüências alélicas dos polimorfismos genéticos da PON1 192QR e 55LM, e ainda, avaliar a correlação destes parâmetros com as alterações lipídicas em indivíduos soropositivos para o HIV-1 tratados com IP. No período de Setembro de 2009 até Junho de 2012, 174 indivíduos soropositivos e 46 soronegativos para o HIV-1 foram estudados. Foi realizada a genotipagem dos polimorfismos da PON1 192QR e 55LM através de PCR-RFLP. A atividade sérica da PON1/ARE foi avaliada por espectrofotometria empregando-se como substratos o paraoxon e o fenilacetato, respectivamente. O RNA-HIV-1 foi quantificado pelo método NASBA, e os linfócitos T-CD4+ e T-CD8+ por citometria de fluxo. Os níveis séricos de colesterol total, HDL, LDL, triglicérides (TG), ApoA1 e ApoB100 foram determinados e os anticorpos IgG anti-oxLDL por ELISA. A atividade sérica da PON1 foi inferior nos grupos de soropositivos, p<0,05, porém, a atividade ARE não apresentou diferenças entre os grupos estudados, p>0,05. Ambas as atividades não apresentaram relação com os genótipos PON1 192QR e 55LM, e estes genótipos apresentaram uma freqüência alélica semelhante ao grupo de soronegativos. Os níveis séricos de TG foram superiores nos grupos de soropositivos com TARV, p<0,05, enquanto o grupo tratado com IP apresentou níveis séricos de HDL e Apo-A1 inferiores aos demais grupos, p<0,05. Níveis séricos de Apo-B100, IgG anti-oxLDL, e o índice de risco aterogênico foram superiores no grupo tratado com IP, p<0,05. Concluí-se, que indivíduos soropositivos para o HIV-1 apresentaram alterações no metabolismo lipídico, principalmente nos tratados com IP, que adicionalmente apresentaram um maior índice de risco aterogênico e maiores níveis de anticorpos IgG anti-oxLDL. Estas alterações não apresentaram relação com os polimorfismos PON1 192QR e 55LM da PON1, e demonstraram que a atividade da enzima PON-1 esta diminuída em indivíduos soropositivos para o HIV-1 / The enzyme Paraoxonase-1 (PON1) has paraoxonase (PON), arylesterase (ARE) and lactonase activities, among others. It is the most studied member of PON family which is composed of PON1, PON2 and PON3. It is suggested that all members acts by inhibiting the peroxidation of lipid molecules as the low-density lipoprotein (LDL) and high-density lipoprotein (HDL), characterizing a potential anti-atherogenic effect. The PON1 gene has two mainly polymorphic sites, with an exchange of Gln192Arg (Q/R) and Met55Leu (L/M), which are associated with differences in activity and serum concentrations of the enzyme. In turn, seropositive individuals for HIV-1 show changes in lipid metabolism, which could be associated with changes in the activity of PON1 and highly active antiretroviral therapy (HAART) with protease inhibitors (PI). The aim of this study was to determinate the serum PON and ARE activities of PON1, the allele frequencies of PON1 192QR and PON1 55LM genetic polymorphisms and evaluate the correlation between these parameters and lipid abnormalities in seropositive patients for HIV-1 treated with IP. In the period from September 2009 until June 2012, 174 seropositive individuals and 46 soronegative individuals for HIV-1 were studied. We performed PON1 192QR and 55LM genotyping by PCR-RFLP. Serum activities PON and ARE of PON1 were evaluated by spectrophotometry using paraoxon and phenylacetate, respectively, as substrates. The HIV-1-RNA was quantified by the NASBA method, and lymphocytes T-CD4+ and T-CD8+, by flow cytometry. Serum levels of total cholesterol, HDL, LDL, triglycerides (TG), apoA1 and ApoB100 were determined. IgG anti-oxLDL antibodies were quantified by ELISA. The serum PON1 activity was lower in the seropositive group, p<0.05, however, ARE activity did not differ between groups, p>0.05. Both activities had no relation with the PON1 192QR and PON1 55LM genotype, and these individuals showed an allele frequency similar to the seronegative group. Serum levels of TG were higher in groups of HIV-positive with HAART, p<0.05, while the IP-treated group showed serum levels of HDL and ApoA1 lower than other groups, p <0.05. Serum levels of ApoB100, IgG anti-oxLDL antibodies, and atherogenic risk indices were higher in the group treated with PI, p<0.05. It was concluded that individuals HIV-1-infected showed changes in lipid metabolism, especially in those treated with IP, which additionally showed a higher rate of atherogenic risk and higher levels of IgG anti-oxLDL antibodies. These changes did not correlated with PON1 192QR and 55LM polymorphisms and demonstrated that the activity of PON1enzyme is decreased in individuals seropositive for HIV-1

Les neurotoxiques organophosphorés sont des agents chimiques qui font partie de la menace NRBC (nucléaire, radiologique, biologique, chimique). Ces agents peuvent pénétrer l'organisme par inhalation, ingestion ou absorption cutanée. La principale voie d'absorption des agents chimiques peu volatils (persistants), tels que le VX et l'ypérite, est la voie cutanée. La décontamination des surfaces cutanées non protégées est donc cruciale pour empêcher une absorption trop importante du toxique et une intoxication. Ce travail s'est attaché à évaluer la capacité de nanoparticules d'oxyde de cérium à adsorber et à dégrader les composés organophosphorés, en utilisant un pesticide organophosphoré, le Paraoxon, et un modèle d'étude in vitro, la peau d'oreille de porc. Les résultats ont montré que la cérine, sous forme de poudre de nanoparticules, dégrade le Paraoxon mais ne permet pas de réduire son absorption à travers la peau. Des formes liquides contenant la cérine (suspension aqueuse, émulsi on de Pickering) ont été développées, pour éviter la dispersion des nanoparticules dans l'air lors de l'utilisation. Elles permettent une élimination plus efficace du Paraoxon, mais l'activité de dégradation de la cérine est très faible. L'influence des conditions de synthèses sur les propriétés physico-chimiques de la cérine en relation avec l'efficacité de dégradation a été étudiée. Les résultats montrent que la surface spécifique est un paramètre clé et que le protocole d'application des décontaminants doit être adapté / The organophosphorus nerve agents form part of chemical agents which pose the NRBC threat (nuclear, radio, biological, chemical). These agents can get into the body by inhalation, ingestion or skin absorption. The main route of chemical agent absorption which are low volatile, as VX or yperite, is the dermal route. Decontamination of unprotected skin areas is crucial to prevent excessive absorption of toxic. This work aimed at evaluating the ability of cerium oxide nanoparticles to adsorb and degrade organophosphorus compounds by using an organophosphorus pesticide, Paraoxon, and an in vitro model, pig-ear skin. The results showed that ceria, in powder form, degraded the Paraoxon but did not allow reducing its absorption through the skin. Liquid forms containing ceria (aqueous suspension, Pickering emulsion) have been formulated in order to avoid the dispersion of particles in the air during its use. While liquid formulations allow more efficient removal of Paraoxon during decontamin ation process, the degradation activity of ceria was low. The influence of the synthesis conditions on the physicochemical properties of ceria linked to degradation efficiency of nanoparticles has been studied. The results showed that specific surface area is the key parameter and that the application protocol of decontaminants must be adapted

Organophosphates (OPs) are a major class of pesticides and nerve agents that elicit acute toxicity by inhibiting acetylcholinesterase (AChE), the enzyme responsible for the degradation of the neurotransmitter acetylcholine in the central and peripheral nervous systems. Acetylcholine accumulation following extensive AChE inhibition leads to an acute cholinergic syndrome characterized by autonomic dysfunction, involuntary movements, muscle fasciculations, respiratory distress, and seizures. Despite their classification as moderate to highly toxic, OP pesticides are the most widely used class of insecticides in the U.S., and are even more commonly used worldwide. Additionally, there is a growing concern that OP nerve agents could be used to cause mass civilian casualties. It is well known that the survivors of acute nerve gas poisoning and chronic OP pesticide exposure exhibit neurobehavioral deficits including mood changes, depression, and memory impairments. Despite this, there are very few treatments available for OP-intoxication survivors and this topic is under-researched. In this study we investigated whether animals surviving a single severe OP exposure exhibited long-term neurological impairments, using two OP agents: paraoxon (POX) and diisopropyl fluorophosphates (DFP), as well as a non-OP chemoconvulsant, pilocarpine (Pilo), which acts as a muscarinic agonist. Exposure to POX, DFP, or Pilo led to overt signs of cholinergic toxicity. POX and DFP rats were rescued with an optimized atropine, 2-PAM, and diazepam therapy per current OP-exposure treatment guidelines, while Pilo rats were given only diazepam. Saline was administered to control rats at all pharmacological timepoints. Surviving rats were studied using established behavioral assays for identifying symptoms of depression and memory impairment 3-6 months after exposure to toxic agents. In the forced swim test, POX, DFP, and Pilo animals exhibited increased immobility time indicative of a despair-like state. In the sucrose preference test, POX, DFP, and Pilo rats did not display a preference for sucrose water, indicating an anhedonia-like condition. POX, DFP, and Pilo rats also displayed increased anxiety as characterized by significantly lower performance in the open arm of the elevated plus maze. Furthermore, when tested with a novel object recognition paradigm, POX, DFP, and Pilo rats exhibited a significantly lower discrimination ratio, indicating impaired recognition memory. The results indicate that these models of survival from severe POX and DFP exposure can be employed to study chronic behavioral and cognitive comorbidities and to further investigate the molecular bases for these comorbidities, potentially leading to the development of pharmacological therapies.

Made available in DSpace on 2011-05-04T12:36:17Z (GMT). No. of bitstreams: 0 Previous issue date: 2009 / Todos os animais com células nervosas e musculares possuem a enzima acetilcolinesterase (EC 3.1.1.7, AChE) e essa seqüência de aminoácidos está presente em muitas outras proteínas, com ou sem atividade catalítica, fato que permite que essa proteína seja utilizada em estudos de filogenia e de evolução. A grande diferença de afinidade entre substratos e inibidores é utilizada como um biomarcador para estudos genéticos de vários grupos de animais, especialmente insetos. Peixes possuem uma grande diferença na sensibilidade da AChE ao metil-paraoxon (MP) em relação aos animais terrestres e essa diferença pode estar relacionada à evolução. As constantes cinéticas de inibição (CCI) para o mecanismo de inibição progressivamente irreversível da AChE cerebral ao MP foram determinadas em duas fontes de AChE como um modelo para avaliação do potencial de uso das CCI como biomarcador para estudos evolucionários e filogenéticos. As CCI da AChE cerebral de seis exemplares de tainha (Mugil liza), coletados em duas lagoas da costa do Estado do Rio de Janeiro (Araruama e Saquarema), em tempos diferentes (2005 e 2007, respectivamente), foram determinadas em dois laboratórios distintos (CESTEH - FIOCRUZ e Dept. Bioquímica - UERJ). As CCI, medidas separadamente em cada exemplar, indicaram que essas constantes são preservadas em todos os exemplares de uma mesma espécie e que a metodologia empregada pode ser conduzida em laboratórios distintos sem grandes variações. A AChE cerebral de tainha foi tomada como um exemplo de enzima menos sensível (IC50 = 2118nM) e a de galinha comercial (Gallus gallus domesticus) como um exemplo de uma enzima muito mais sensível ao MP (IC50 = 26nM). Alguns testes foram feitos para a validação dessa metodologia. A AChE cerebral dessas duas fontes de enzima foi parcialmente purificada descartando o sobrenadante do homogeneizadoe solubilizando o sedimento com o detergente Triton X-100. A inibição da atividade de AChE nessas preparações pelo substrato acetiltiocolina, comportamento típico da AChE, comprovou a homogeneidade dessa atividade enzimática como representativa da AChE verdadeira em cada animal. A utilização do MP permitiu aferir as soluções de inibidorcom métodos colorimétricos no momento do uso e a preparação solúvel de AChE eliminou artefatos insolúveis que atrapalham a quantificação da enzima. Algumas características matemáticas do cálculo das CCI foram discutidas e um modelo foi validado para ser utilizado em estudos de evolução e filogenia de peixes marinhos da costa brasileira. Como a AChE cerebral de todos os animais terrestres, cujos resultados estão disponíveis, é muito mais sensível ao MP, exemplares de uma espécie de baiacu (baiacu-arara, Lagocephaluslaevigatus) foram testados como um exemplo de peixe mais jovem na escala evolutiva. Os resultados das CCI da AChE cerebral para essa espécie (IC50 = 2243nM) indicaram que entre os peixes a idade evolutiva não está correlacionada com a sensibilidade aos organofosforados. A AChE mais sensível entre os peixes testados foi a de um tipo de bagre (bagre-branco, Genidens barbus, IC50 = 606nM) e a enzima do cação-frango (Rhizoprionodonporosus), exemplo de um peixe mais antigo na evolução, apresentou uma sensibilidade intermediária (IC50 = 1280nM). Estudos com outras espécies correlacionadas com aquelas que se mostraram mais sensíveis ao MP terão que ser feitos para uma resposta mais adequada sobre o uso das CCI de inibição da AChE cerebral por MP como possível marcador evolutivo e filogenético. / The enzyme acetylcholinesterase (EC 3.1.1.7, AChE) is present in all animals with neurons and muscle cells, and many other proteins have the same sequence, with or without catalytic activity, allowing them to be used for phylogenetic and evolutionary studies. The great difference between substrates and inhibitor affinities makes it useful as a biomarker for genetic studies of various animals groups, especially insects. There are great differences among fish in AChE sensitivity to methyl-paraoxon (MP) in relation to terrestrial animals, and these differences can be related to evolution. The inhibition kinetic constants (IKC) for progressive irreversible inhibition of brain AChE with MP were determined in these two AChE sources as models for evaluating IKC as potential biomarkers in evolutionary and phylogenetic studies, especially among fish. IKC of brain AChE from six specimens of Mugil liza, a very common coastal fish, was collected from two of Brazil's lagoons in Rio de Janeiro State during 2005 at Araruama and 2007 at Saquarema. First samples were assayed at CESTEH - Fundação Oswaldo Cruz and the latter at Dept. Bioquímica - Universidade do Estado do Rio de Janeiro. The IKC was measured separately for each fish showing that these constants were maintained for all animals of the same species and that this methodology can be used in different laboratories without variations. The cerebral AChE of tainha was used as an example of a less sensitive enzyme (Concentration which inhibits 50% of enzyme activity after 30 minutes of incubation, or IC50, = 2118nM). The commercial hen (Gallus gallus domesticus) was used an example of a very highly sensitive enzyme to MP (IC50 = 26nM). Some tests were carried out to validate this methodology. The cerebral AChE of these two sources of enzyme was partially purified discarding the supernatant of the homogenate and solubilizing the pellet with Triton X-100 detergent. The AChE activity inhibition in these preparations by excess of the substrate acetylthiocholine, a typical AChE behaviour, proved the homogeneity of this preparation and that it is representative of the real AChE of each animal. Using MP allows checking out the solutions of inhibitor with colorimetric methods in the moment of use. The preparation of soluble AChE eliminates insoluble matters which confound the enzyme quantification. Some characteristics of mathematical calculations of IKC were defined to create a valid model that is able to be used for evolutionary and phylogenic studies of fish and other animals. The cerebral AChE of all terrestrial animals, whose results are available, is highly sensitive to MP. To compare with a similar recently evolved fish, a sample of baiacu (baiacu-arara, Lagocephalus laevigatus) was tested for IKC and the results (IC50 = 2243nM) indicated that evolutionary age of the fish does not correlate with sensitivity to organophosphorus compounds. The most sensitive AChE among the fish tested was a type of catfish (bagre-branco, Genidens barbus, IC50 = 606nM) and the enzyme of an older evolved fish, a small shark (cação-frango, Rhizoprionodon porosus), had an intermediate sensitivity (IC50 = 1280nM). Studies with other species correlated to those being more sensitive to MP have to be made to get adequate answers about the use of IKC for cerebral AChE inhibition by MP as a possible evolutionary and phylogenetic marker.

L'étude porte sur une électrode à butyrylcholinestérase immobilisée, destinée à la détection de pesticides et insecticides inhibiteurs de cette enzyme, en particulier les organophosphorés et les carbamates. Les conditions optimales de mise au point et d'utilisation de cette électrode sont étudiées, ainsi que son comportement en présence d'inhibiteurs solubles dans l'eau, représentés, par le paraoxon. La détection d'inhibiteurs insolubles dans l'eau est effectuée dans un mélange tampon phosphate-éthanol ou méthanol. Le champ des interférences connues est élargi aux sels d'halogénures, et les possibilités de régénération de la butyrylcholinestérase inhibée optimisées. La détection en routine d'inhibiteurs dans les eaux exposées à des risques de pollution accidentelle est mise au point grâce à un ensemble automatisé, dont le fonctionnement est explicité. Un modèle théorique permet d'expliciter certains résultats de l'expérience.

This thesis describes the characterization of SsoPox, a lactonase with promiscuous phosphotriesterase activity from the hyperthermophilic archaeon, Sulfolobus solfataricus, and the potential of the phosphotriesterase from Brevundimonas diminuta (PTEBd) to function as an organophosphate sensor. Arg-223 and Tyr-99 of SsoPox are not essential for lactonase activity, however substitution of a phenylalanine in place of Tyr-97 abolished lactonase activity while reducing paraoxonase activity by 20-fold. Substrate specificity of SsoPox can be modulated through the partial blockage of the hydrophobic binding tunnel adjacent to the active site. The specificity constant for N-(3-oxo-decanoyl)-L-homoserine lactone decreased 37-fold when a phenylalanine was introduced in place of Leu-226. PTEBd was expressed and purified from Pseudomonas putida and, like SsoPox, can be immobilized to Disruptor paper. The immobilized enzyme can be used to detect five organophosphates at concentrations as low as 50 μM. Incubation of PTEBd-immobilized sensors at different temperatures proved that the enzyme is stable for at least 40 days at 23.5 degrees Celsius without any detectable change in activity.